Trevi Therapeutics TRVI
NASDAQ TRVI
$13.91 -0.27 (-1.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Other Non Operating Income (2021 - 2022)

Updated

Trevi Therapeutics (TRVI) reported Other Non Operating Income of -$31,000 for FY2025, compared with -$15,000 in FY2024.

Analysis

Trevi Therapeutics (TRVI) Other Non Operating Income (2021 - 2022) Analysis & Trends

Dating back to FY2020, Trevi Therapeutics' Other Non Operating Income record includes 6 years.

  • The FY2025 figure ranks as the lowest annual Other Non Operating Income since FY2021.
  • According to Business Quant data, Other Non Operating Income came in at -$15,000 in FY2024, $469,000 in FY2023 (+62.3%), $289,000 in FY2022 and -$375,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Trevi Therapeutics 1.98 Bn 1.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 436,000.00
Jun 30, 2022 -136,000.00
Mar 31, 2022 -11,000.00
Dec 31, 2021 -750,000.00
Sep 30, 2021 -5,000.00
Jun 30, 2021 375,000.00
Mar 31, 2021 -6,000.00
API Access

Trevi Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TRVI&period=max&api_key=YOUR_API_KEY